Body dysmorphic disorder (BDD) is treated with a specific form of cognitive behavioral therapy (CBT) and, often, antidepressant medication that targets serotonin. These two approaches, used alone or together, are the established first-line treatments. Unlike many appearance-related concerns, BDD does not improve with cosmetic procedures, and the path to recovery looks quite different from what most people expect.
CBT Tailored for BDD
The recommended psychological treatment is not generic talk therapy. It’s a structured form of CBT designed specifically for BDD, typically delivered over 16 to 24 sessions. The therapy has several core components: psychoeducation (learning how BDD works in the brain), cognitive restructuring (identifying and challenging distorted beliefs about appearance), exposure and ritual prevention, mindfulness-based perceptual retraining, and relapse prevention planning.
Exposure and ritual prevention (ERP) is the behavioral engine of the treatment. You work with your therapist to gradually enter situations that trigger anxiety about your appearance, like going out without makeup, sitting under bright lighting, or allowing someone to see you from a certain angle. The critical piece is that you do this while resisting the rituals BDD drives you toward: mirror checking, seeking reassurance, adjusting clothing, or mentally comparing yourself to others. Over time, your brain learns that the feared outcome doesn’t happen, and the distress fades.
Cognitive restructuring targets the thinking patterns that fuel BDD. You might believe, for example, that everyone in the room is staring at the feature you’re fixated on. Therapy helps you test those beliefs against evidence and develop more realistic interpretations. Perceptual retraining uses mindfulness techniques to shift how you actually see yourself, since people with BDD tend to hyperfocus on specific details rather than perceiving their appearance as a whole.
In a randomized controlled trial comparing BDD-specific CBT to supportive psychotherapy (general, non-structured therapy), 68% of people who received CBT achieved full or partial remission by the end of treatment, compared to 42% with supportive therapy. At six months, 52% of the CBT group maintained sustained remission, and those who reached remission showed meaningful improvements in daily functioning, depression, quality of life, and even insight into their condition. About 18% of people who completed CBT never achieved remission, which underscores that it works for most but not everyone.
Medication: Higher Doses, Longer Timelines
The medications that work for BDD are serotonin reuptake inhibitors (SRIs), a class that includes most common antidepressants like fluoxetine (Prozac), sertraline (Zoloft), and escitalopram (Lexapro). These are the same drugs prescribed for depression and OCD, but BDD typically requires higher doses and more patience.
A medication trial for BDD is considered adequate only after at least 12 weeks at the maximum recommended dose, or sometimes above it. That’s significantly longer than the 4 to 6 weeks often used to evaluate antidepressants for depression. The doses tend to run higher too. In clinical practice, the average daily doses used for BDD patients are roughly 67 mg of fluoxetine (versus the typical 20 mg starting dose for depression), 202 mg of sertraline (versus a typical 50 to 100 mg range), and 29 mg of escitalopram (versus 10 to 20 mg). Some patients benefit from doses that exceed what pharmaceutical manufacturers officially recommend.
This means that if you try an SSRI at a standard dose for a few weeks and don’t notice improvement, that doesn’t mean the medication has failed. Your prescriber may need to increase the dose gradually and wait the full 12 weeks before drawing conclusions. In a head-to-head trial, the older antidepressant clomipramine outperformed a non-serotonin antidepressant for BDD symptoms, confirming that serotonin is the key mechanism. Non-serotonin antidepressants are not effective for BDD.
What Happens When First-Line Treatment Isn’t Enough
For people who don’t respond adequately to an SSRI alone, the options become less clear-cut. Unlike OCD, where adding a low-dose antipsychotic medication to an SSRI sometimes helps, the evidence for that strategy in BDD is weak. One controlled trial of antipsychotic augmentation in BDD was negative, and guidelines do not recommend this approach based on current data.
Combining CBT and medication is a common strategy when one alone isn’t sufficient. Your clinician may also try switching to a different SSRI, since people sometimes respond to one but not another, or may push the dose higher if it’s been tolerated well. The treatment process for BDD often involves more trial and adjustment than for straightforward depression.
Why Cosmetic Procedures Don’t Work
This is one of the most important things to understand about BDD. Because the distress feels like it’s about a specific physical feature, many people pursue cosmetic surgery, dermatological treatments, or minimally invasive procedures like fillers and Botox. The results are almost universally disappointing.
In a study of 87 surgical and minimally invasive cosmetic procedures received by people with BDD, only 2.3% led to longer-term improvement in overall BDD symptoms. That means 97.7% of procedures resulted in no meaningful change or made things worse. The pattern held across procedure types: surgical, minimally invasive, dermatological, and dental treatments all showed similarly poor outcomes. When researchers compared cosmetic surgery to all other non-psychological treatments, improvement rates were statistically indistinguishable (1.6% versus 4.0%).
The reason is that BDD is a brain-based disorder, not an appearance problem. The distress originates from how the brain processes and interprets visual information about the body, not from the physical feature itself. Changing the feature doesn’t change the underlying processing error, so people with BDD typically shift their fixation to a new perceived flaw, feel that the procedure made things worse, or become preoccupied with imperfections in the surgical result.
Tracking Progress
Clinicians measure BDD severity using a tool called the BDD-YBOCS (a modified version of the Yale-Brown Obsessive Compulsive Scale). It’s a 12-item assessment that rates how much time you spend preoccupied with your appearance, how much distress the thoughts cause, how much they interfere with your daily life, and how much control you have over the compulsive behaviors. Your therapist or psychiatrist will likely use this or a similar scale periodically to gauge whether treatment is working. If you’re curious about your own progress, you can ask about your score and what direction it’s trending.
Severe BDD and Hospitalization
When BDD becomes so severe that you can’t keep up with daily responsibilities, or if it leads to a mental health crisis, inpatient psychiatric care may be necessary. Hospitalization for BDD focuses on stabilization rather than full treatment. The stays are typically brief, centered on managing immediate safety and beginning targeted interventions. Because CBT and ERP require sustained work over weeks to months, the real therapeutic progress happens after discharge, through outpatient appointments. The hospital serves as a bridge to get someone stable enough to engage in that longer-term care.
What Recovery Looks Like
Recovery from BDD doesn’t mean you’ll never have a negative thought about your appearance again. It means the preoccupation loosens its grip. You spend less time checking, less time avoiding, and the emotional weight of those thoughts decreases significantly. People in remission report being able to go about their day without appearance-related thoughts dominating their attention.
Relapse is a real possibility. In the randomized trial mentioned earlier, about 20% of people who achieved remission with CBT experienced recurrence within six months. That’s why relapse prevention is built into the therapy itself. You learn to recognize early warning signs, like increased mirror checking or avoidance of social situations, and to re-apply the skills before symptoms escalate. Many people also benefit from periodic “booster” sessions after their main course of therapy ends.
The combination of realistic expectations, commitment to the full course of treatment (not stopping at week 6 of medication or session 8 of therapy), and understanding that cosmetic fixes won’t help puts people in the strongest position for lasting improvement.